Details for 2012730099

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATION AUS PANOBINOSTAT UND RUXOLITINIB BEI DER BEHANDLUNG VON KREBS WIE ETWA EINEM MYELOPROLIFERATIVEN NEOPLASMA

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012730099

EP Publication Number

2720696

E-Number

801667

Language

PCT Number

US12042174

Publication Date

23.04.2014 A

25.05.2016 B1

Registration Date

25.05.2016

AT Publication Date

15.06.2016

Application Date

13.06.2012

Registration Number

Priorities

14.06.2011

201161496750 P

09.12.2011

201161568717 P

IPC

A61K 31/4045 20060101AFI20130109BHEP

Maximum Duration of Protection

13.06.2032

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

BAFFERT, FabienneNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

RADIMERSKI, ThomasNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

GADBAW, BrianNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US